1st Edition
Antimicrobial Resistance Collaborative Measures of Control
Antimicrobial resistance has existed in nature long before the discovery of antibiotics. The mechanisms of resistance are prevalent among the bacterial population. Over a period of time and facilitated by indiscriminate usage of antibiotics, these mechanisms are transferred from one type of bacteria to another, including the pathogenic ones. In addition, the rate of discovery of novel antimicrobials is much slower than the rate of evolution of antimicrobial resistance. Therefore, there is a need for alternative strategies to control antimicrobial resistance to save lives. In this book, the novel strategies to combat antimicrobial resistance are described, emphasizing collaborative measures of control. We describe the concerted efforts undertaken by global communities to combat antimicrobial resistance in detail. The most efficient strategy could be a behavioral change towards indiscriminate consumption, usage, and prescription of antibiotics.
Microbial Threats - The AMR pandemic
Rajashri Banerji and Sunil D. Saroj
Diversity in the Development and Transmission of AMR
Riya Joshi, Agnita Roychowdhury, and Sunil D. Saroj
Alternatives to Combat AMR: Hunt for Novel Antimicrobials
Amrita Bhagwat, Tiyasa Haldar, and Sunil D. Saroj
Antimicrobials in Growth and Development
Ujjayni Saha, Ranjika Bhattacharya, and Sunil D. Saroj
Antimicrobial and Antibiotic Resistance in Developing Countries: Health Economics, Global Governance, and Sustainable Development Goals
Stefano Greco, Romans Putans, and Lauma Springe
Disease Economics: Economic aspects of Anti-Bacterial and Anti-Microbial Resistance: Comparative analysis of Europe and other world regions
Romans Putans and Lauma Springe
Leveraging Health Diplomacy in achieving AMR Policy Coherence
Sanjay Pattanshetty and Helmut Brand
AMR policies and Implementation issues: Developed vs Developing Countries
Himanshu Sekhar Pradhan, Jyoti Prakash, Kiranjeet Kaur, Mousumi Samal, and Sudhir Kumar Satpathy
Implementation Challenges in Healthcare-associated Antimicrobial Resistance Prevention and Control in India
Prakash Narayanan, Rakshitha K, and Helmut Brand
Combating AMR through Behavior Change : Role of Higher Education Institutes
Meenakshi Sood, Vinay Kumari, and Bunty Sharma
Behavioural Change: Role of NGOs to Combat AMR
Dona Boban, Kiranjeet Kaur, and Sanjeev K Singh
Measures in Preserving the effectiveness of Existing Antimicrobials
Himanshu Sekhar Pradhan, Jyoti Prakash, Mousumi Samal, and Sudhir Kumar Satpathy
Technology Solutions to AMR: Focus Paediatric Population
Preethi John, Shweta Jindal, Deena Mariyam, and Honey Tandon
Human resources capacity building for AMR Stewardship programme
Preethi John, Navneet Kaur Bains, Sandhya Vashisht, and Keerti Bhusan Pradhan
Combating AMR- One Health Approach
Dona Boban, Kiranjeet Kaur, and Sanjeev K Singh
Index
Biography
Dr. Sunil D. Saroj (Associate Professor, Symbiosis School of Biological Sciences, Symbiosis International (Deemed University), India) During my Ph.D. in Microbiology from the Bhabha Atomic Research Centre, India, I was exposed to the fascinating life of microbes. Bacterial pathogens have efficient mechanisms to overcome the stress that could affect their growth and survival. The stress factors include both growth-promoting and growth-inhibiting molecules. The biggest challenge the bacterial pathogens must face is from antimicrobials, bacteriophages, and the host immune system. In nature, these bacterial pathogens are present in close association with other bacteria and their hosts. To overcome these challenges and preserve their existence, the bacteria have developed communication systems, wherein they share chemical and genetic information with the other bacteria. The role of these interspecies communications in virulence and antimicrobial resistance was pursued further during my post-doctoral experience at the Chiba University (Japan), Emory University (USA), and Stockholm University (Sweden). I understand that the issue of antimicrobial resistance could not be resolved by just discovery of novel antibiotics; additional novel intervention strategies are required.
